Literature DB >> 20483731

Commensal Escherichia coli reduces epithelial apoptosis through IFN-alphaA-mediated induction of guanylate binding protein-1 in human and murine models of developing intestine.

Julie Mirpuri1, Jennifer C Brazil, Andrew J Berardinelli, Tala R Nasr, Kiesha Cooper, Michael Schnoor, Patricia W Lin, Charles A Parkos, Nancy A Louis.   

Abstract

Appropriate microbial colonization protects the developing intestine by promoting epithelial barrier function and fostering mucosal tolerance to luminal bacteria. Commensal flora mediate their protective effects through TLR9-dependent activation of cytokines, such as type I IFNs (alpha, beta) and IL-10. Although IFN-beta promotes apoptosis, IFN-alpha activates specific antiapoptotic target genes whose actions preserve epithelial barrier integrity. We have recently identified guanylate binding protein-1 (GBP-1) as an antiapoptotic protein, regulated by both type I and type II IFNs, that promotes intestinal epithelial barrier integrity in mature intestine. However, the mechanisms by which commensal bacteria regulate epithelial apoptosis during colonization of immature intestine and the contributions of GBP-1 are unknown. The healthy newborn intestine is initially colonized with bacterial species present in the maternal gastrointestinal tract, including nonpathogenic Escherichia coli. Therefore, we examined the influence of commensal E. coli on cytokine expression and candidate mediators of apoptosis in preweaned mice. Specifically, enteral exposure of 2 wk-old mice to commensal E. coli for 24 h selectively increased both IFN-alphaA and GBP-1 mRNA expression and prevented staurosporine-induced epithelial apoptosis. Exogenous IFN-alphaA treatment also induced GBP-1 expression and protected against staurosporine-induced apoptosis in a GBP-1 dependent manner, both in vitro and ex vivo. These findings identify a role for IFN-alphaA-mediated GBP-1 expression in the prevention of intestinal epithelial apoptosis by commensal bacteria. Thus IFN-alphaA mediates the beneficial effects of commensal bacteria and may be a promising therapeutic target to promote barrier integrity and prevent the inappropriate inflammatory responses seen in developing intestine as in necrotizing enterocolitis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20483731      PMCID: PMC3145319          DOI: 10.4049/jimmunol.0903116

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  69 in total

Review 1.  Intestinal microbiota development in the premature neonate: establishment of a lasting commensal relationship?

Authors:  Maka Mshvildadze; Josef Neu; Volker Mai
Journal:  Nutr Rev       Date:  2008-11       Impact factor: 7.110

2.  The influence of apoptosis on intestinal barrier integrity in rats.

Authors:  Z Sun; X Wang; R Wallen; X Deng; X Du; E Hallberg; R Andersson
Journal:  Scand J Gastroenterol       Date:  1998-04       Impact factor: 2.423

3.  Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis.

Authors:  M Schnoor; A Betanzos; D A Weber; C A Parkos
Journal:  Mucosal Immunol       Date:  2008-09-17       Impact factor: 7.313

4.  Interferon beta induces mature dendritic cell apoptosis through caspase-11/caspase-3 activation.

Authors:  Jui-Hung Yen; Doina Ganea
Journal:  Blood       Date:  2009-06-16       Impact factor: 22.113

Review 5.  The long-term health effects of neonatal microbial flora.

Authors:  Michelle E Conroy; Hai Ning Shi; W Allan Walker
Journal:  Curr Opin Allergy Clin Immunol       Date:  2009-06

6.  Molecular beacons: a real-time polymerase chain reaction assay for detecting Escherichia coli from fresh produce and water.

Authors:  S Sandhya; Wilfred Chen; Ashok Mulchandani
Journal:  Anal Chim Acta       Date:  2008-03-19       Impact factor: 6.558

Review 7.  Bacterial colonization, probiotics, and necrotizing enterocolitis.

Authors:  Erika C Claud; W Allan Walker
Journal:  J Clin Gastroenterol       Date:  2008-07       Impact factor: 3.062

8.  Reciprocal expression and signaling of TLR4 and TLR9 in the pathogenesis and treatment of necrotizing enterocolitis.

Authors:  Steven C Gribar; Chhinder P Sodhi; Ward M Richardson; Rahul J Anand; George K Gittes; Maria F Branca; Adam Jakub; Xia-hua Shi; Sohail Shah; John A Ozolek; David J Hackam
Journal:  J Immunol       Date:  2009-01-01       Impact factor: 5.422

9.  Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants.

Authors:  C Michael Cotten; Sarah Taylor; Barbara Stoll; Ronald N Goldberg; Nellie I Hansen; Pablo J Sánchez; Namasivayam Ambalavanan; Daniel K Benjamin
Journal:  Pediatrics       Date:  2009-01       Impact factor: 7.124

10.  The probiotic Lactobacillus GG may augment intestinal host defense by regulating apoptosis and promoting cytoprotective responses in the developing murine gut.

Authors:  Patricia W Lin; Tala R Nasr; Andrew J Berardinelli; Amrita Kumar; Andrew S Neish
Journal:  Pediatr Res       Date:  2008-11       Impact factor: 3.756

View more
  23 in total

1.  Human T cell leukemia virus type I tax-induced IκB-ζ modulates tax-dependent and tax-independent gene expression in T cells.

Authors:  Ryuichiro Kimura; Masachika Senba; Samuel J Cutler; Stephen J Ralph; Gutian Xiao; Naoki Mori
Journal:  Neoplasia       Date:  2013-09       Impact factor: 5.715

2.  Proteobacteria-specific IgA regulates maturation of the intestinal microbiota.

Authors:  Julie Mirpuri; Megan Raetz; Carolyn R Sturge; Cara L Wilhelm; Alicia Benson; Rashmin C Savani; Lora V Hooper; Felix Yarovinsky
Journal:  Gut Microbes       Date:  2013-09-25

Review 3.  Biological pathways involved in the development of inflammatory bowel disease.

Authors:  Mateja Zemljic; Bozena Pejkovic; Ivan Krajnc; Saska Lipovsek
Journal:  Wien Klin Wochenschr       Date:  2014-09-26       Impact factor: 1.704

4.  Commensal and probiotic bacteria may prevent NEC by maturing intestinal host defenses.

Authors:  Brett M Jakaitis; Patricia W Denning
Journal:  Pathophysiology       Date:  2014-01-17

Review 5.  Pathophysiological role of guanylate-binding proteins in gastrointestinal diseases.

Authors:  Nathalie Britzen-Laurent; Christian Herrmann; Elisabeth Naschberger; Roland S Croner; Michael Stürzl
Journal:  World J Gastroenterol       Date:  2016-07-28       Impact factor: 5.742

6.  Human milk mucin 1 and mucin 4 inhibit Salmonella enterica serovar Typhimurium invasion of human intestinal epithelial cells in vitro.

Authors:  Bo Liu; Zhuoteng Yu; Ceng Chen; David E Kling; David S Newburg
Journal:  J Nutr       Date:  2012-06-20       Impact factor: 4.798

Review 7.  The guanylate-binding proteins: emerging insights into the biochemical properties and functions of this family of large interferon-induced guanosine triphosphatase.

Authors:  Deborah J Vestal; Jonathan A Jeyaratnam
Journal:  J Interferon Cytokine Res       Date:  2010-12-13       Impact factor: 2.607

Review 8.  An Immunological Perspective on Neonatal Sepsis.

Authors:  Bernard Kan; Hamid Reza Razzaghian; Pascal M Lavoie
Journal:  Trends Mol Med       Date:  2016-03-15       Impact factor: 11.951

Review 9.  Human breast milk and the gastrointestinal innate immune system.

Authors:  Brett M Jakaitis; Patricia W Denning
Journal:  Clin Perinatol       Date:  2014-06       Impact factor: 3.430

Review 10.  The role of type I interferons in intestinal infection, homeostasis, and inflammation.

Authors:  Hyeseon Cho; Brian L Kelsall
Journal:  Immunol Rev       Date:  2014-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.